Debt to EBITDA ratio Analysis of GlaxoSmithKline PLC ADR - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointDebt to EBITDA of GSK
Dec-232.23Good Debt to EBITDA | Dec-222.36Good Debt to EBITDA | Growth-5.60% |
Debt to EBITDA Analysis of GlaxoSmithKline PLC ADR
| Debt to EBITDA Ratio of GSK has fallen by -5.60 % Compared to previous Financial Year. |
| Debt to EBITDA Ratio with value of 3.35 was highest in Year Dec-19 in last Five Years. |
| Debt to EBITDA Ratio of GSK trending down for at least three Years. |
| Latest Debt to EBITDA Ratio with value of 2.23 is lower than Average Debt to EBITDA of 2.69 in last five years. |
Other Debt to EBITDA Related Info of GSK that may interest you.
GlaxoSmithKline PLC ADR Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| GSK | 44.77 | 44.02 | 1.70 % | Drug Manufacturers-General |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..
Debt to EBITDA Related Ratios
| CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
| Low Stability Stock | |
FY - Historical Debt to EBITDA of GlaxoSmithKline PLC ADR
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| Debt to EBITDA | 2.23 | 2.36 | 2.65 | 2.85 | 3.35 | 3.72 | 3.07 |
| Change | -5.60 % | -10.81 % | -6.86 % | -14.90 % | -9.94 % | 20.87 % | -29.84 % |
FY Chart of Debt to EBITDA of GlaxoSmithKline PLC ADR
Note : All Data Generated at the End of Trading Hours (EOD Data)